HealthFortuneabout 2 hours ago
Bank of America spends $250M yearly on weight-loss drugs
4 min read
Bank of America spends $250 million or more annually on GLP-1 weight-loss drugs for staff, part of a $2 billion yearly wellness package. CEO Brian Moynihan says the investment lowers heart issues and supports employee health. About 30% of workers would switch jobs for GLP-1 coverage.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
